• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Resolving the negative data publication dilemma in translational stroke research.解决转化性中风研究中的负面数据发表困境。
Transl Stroke Res. 2011 Mar 1;2(1):1-6. doi: 10.1007/s12975-010-0057-x.
2
Dealing with publication bias in translational stroke research.应对转化性中风研究中的发表偏倚
J Exp Stroke Transl Med. 2009;2(1):16-21. doi: 10.6030/1939-067x-2.1.16.
3
Erythropoietin molecules to treat acute ischemic stroke: a translational dilemma!用促红细胞生成素治疗急性缺血性脑卒中：一个转化难题！
Expert Opin Investig Drugs. 2010 Oct;19(10):1179-86. doi: 10.1517/13543784.2010.517954.
4
Do stroke models model stroke?中风模型能否模拟中风？
Dis Model Mech. 2012 Nov;5(6):718-25. doi: 10.1242/dmm.010033.
5
Reframing the perception of outliers and negative data in translational research.重新构建转化研究中外显子和负性数据的认知。
Brain Res Bull. 2023 Jan;192:203-207. doi: 10.1016/j.brainresbull.2022.11.020. Epub 2022 Dec 1.
6
Novel translational model of resolving inflammation triggered by UV-killed E. coli.新型翻译模型可解决由 UV 杀死的大肠杆菌引发的炎症。
J Pathol Clin Res. 2016 May 4;2(3):154-65. doi: 10.1002/cjp2.43. eCollection 2016 Jul.
7
Positive interactions may decrease cooperation in social dilemma experiments.积极的互动可能会减少社会困境实验中的合作。
Sci Rep. 2019 Jan 31;9(1):1017. doi: 10.1038/s41598-018-37674-5.
8
Addressing the translational dilemma: dynamic knowledge representation of inflammation using agent-based modeling.解决转化困境：使用基于智能体的建模对炎症进行动态知识表示。
Crit Rev Biomed Eng. 2012;40(4):323-40. doi: 10.1615/critrevbiomedeng.v40.i4.70.
9
Resolving the Rigor versus Respect Dilemma in Community-Based Research: Commentary on Bess and Colleagues.
Prog Community Health Partnersh. 2019;13(4):397-400. doi: 10.1353/cpr.2019.0068.
10
Evidence of publication bias in reporting acute stroke clinical trials.急性中风临床试验报告中发表偏倚的证据。
Neurology. 2006 Sep 26;67(6):973-9. doi: 10.1212/01.wnl.0000237331.16541.ac.

引用本文的文献

1
Glibenclamide does not improve outcome following severe collagenase-induced intracerebral hemorrhage in rats.格列本脲不能改善胶原酶诱导的大鼠严重脑出血后的预后。
PLoS One. 2021 Jun 3;16(6):e0252584. doi: 10.1371/journal.pone.0252584. eCollection 2021.
2
Cytoprotective Drug-Tissue Plasminogen Activator Protease Interaction Assays: Screening of Two Novel Cytoprotective Chromones.细胞保护药物 - 组织纤溶酶原激活物蛋白酶相互作用测定：两种新型细胞保护色酮的筛选
Transl Stroke Res. 2017 Apr 12. doi: 10.1007/s12975-017-0533-7.
3
Translational Stroke Research Opportunities and a Strategy to Develop Effective Cytoprotection.转化性中风研究机遇与开发有效细胞保护作用的策略
Transl Stroke Res. 2017 Aug;8(4):318-321. doi: 10.1007/s12975-017-0529-3. Epub 2017 Mar 8.
4
An Outcome Model for Intravenous rt-PA in Acute Ischemic Stroke.急性缺血性脑卒中静脉 rt-PA 治疗的结局模型。
Transl Stroke Res. 2015 Dec;6(6):451-7. doi: 10.1007/s12975-015-0427-5. Epub 2015 Sep 19.
5
A blinded, randomized study of L-arginine in small clot embolized rabbits.一项关于L-精氨酸在小血栓栓塞兔中的双盲、随机研究。
Exp Neurol. 2015 Apr;266:143-6. doi: 10.1016/j.expneurol.2015.02.016. Epub 2015 Feb 20.
6
Effect of the Pleiotropic Drug CNB-001 on Tissue Plasminogen Activator (tPA) Protease Activity in vitro: Support for Combination Therapy to Treat Acute Ischemic Stroke.多效性药物CNB-001对组织型纤溶酶原激活剂（tPA）体外蛋白酶活性的影响：对治疗急性缺血性中风联合疗法的支持。
J Neurol Neurophysiol. 2014 Aug;5(4).
7
Bipyridine, an iron chelator, does not lessen intracerebral iron-induced damage or improve outcome after intracerebral hemorrhagic stroke in rats.双吡啶，一种铁螯合剂，不能减轻脑出血大鼠脑内铁诱导的损伤或改善预后。
Transl Stroke Res. 2013 Dec;4(6):719-28. doi: 10.1007/s12975-013-0272-3. Epub 2013 Aug 6.
8
Fast neuroprotection (fast-NPRX) for acute ischemic stroke victims: the time for treatment is now.急性缺血性中风患者的快速神经保护（Fast-NPRX）：现在是治疗的时候了。
Transl Stroke Res. 2013 Dec;4(6):704-9. doi: 10.1007/s12975-013-0303-0. Epub 2013 Nov 7.
9
Drug-like property profiling of novel neuroprotective compounds to treat acute ischemic stroke: guidelines to develop pleiotropic molecules.新型神经保护化合物治疗急性缺血性脑卒中的类药性特征分析：开发多效分子的指南。
Transl Stroke Res. 2013 Jun;4(3):328-42. doi: 10.1007/s12975-012-0200-y.
10
Vascular Dysfunction in Brain Hemorrhage: Translational Pathways to Developing New Treatments from Old Targets.脑出血中的血管功能障碍：从旧靶点开发新疗法的转化途径
J Neurol Neurophysiol. 2011;2011. doi: 10.4172/2155-9562.S1-e001.

本文引用的文献

1
A Combined Treatment with Taurine and Intra-arterial Thrombolysis in an Embolic Model of Stroke in Rats: Increased Neuroprotective Efficacy and Extended Therapeutic Time Window.牛磺酸与动脉内溶栓联合治疗大鼠栓塞性脑卒中模型：增加神经保护作用和延长治疗时间窗。
Transl Stroke Res. 2011 Mar;2(1):80-91. doi: 10.1007/s12975-010-0050-4. Epub 2010 Nov 16.
2
Short period of early reperfusion aggravates blood-brain barrier dysfunction during permanent focal ischemia in rats.短暂的早期再灌注加重大鼠永久性局灶性缺血期间的血脑屏障功能障碍。
Transl Stroke Res. 2011 Mar;2(1):67-71. doi: 10.1007/s12975-010-0042-4. Epub 2010 Sep 4.
3
Do current animal models of intracerebral hemorrhage mirror the human pathology?目前的脑出血动物模型是否反映了人类的病理学？
Transl Stroke Res. 2011 Mar;2(1):17-25. doi: 10.1007/s12975-010-0037-1. Epub 2010 Aug 10.
4
Opportunities and challenges in omics.组学中的机遇与挑战。
Transl Stroke Res. 2010 Dec 1;1(4):233-7. doi: 10.1007/s12975-010-0048-y.
5
Are Underlying Assumptions of Current Animal Models of Human Stroke Correct: from STAIRs to High Hurdles?目前的人类中风动物模型的基本假设是否正确：从 STAIRs 到高障碍？
Transl Stroke Res. 2011 Jun;2(2):138-43. doi: 10.1007/s12975-011-0067-3. Epub 2011 Feb 12.
6
CeeTox™ Analysis of CNB-001 a Novel Curcumin-Based Neurotrophic/Neuroprotective Lead Compound to Treat Stroke: Comparison with NXY-059 and Radicut.CNB-001 的 CeeTox 分析——一种新型姜黄素类神经营养/神经保护先导化合物，用于治疗中风：与 NXY-059 和 Radicut 的比较。
Transl Stroke Res. 2011 Mar;2(1):51-9. doi: 10.1007/s12975-010-0034-4.
7
Subarachnoid Hemorrhage Induces Gliosis and Increased Expression of the Pro-inflammatory Cytokine High Mobility Group Box 1 Protein.蛛网膜下腔出血诱导神经胶质增生和促炎细胞因子高迁移率族蛋白 1 表达增加。
Transl Stroke Res. 2011 Mar 1;2(1):72-9. doi: 10.1007/s12975-010-0052-2.
8
High and Low Molecular Weight Fluorescein Isothiocyanate (FITC)-Dextrans to Assess Blood-Brain Barrier Disruption: Technical Considerations.高分子量和低分子量异硫氰酸荧光素（FITC）-葡聚糖评估血脑屏障破坏：技术考虑因素。
Transl Stroke Res. 2011 Mar;2(1):106-11. doi: 10.1007/s12975-010-0049-x. Epub 2010 Nov 11.
9
Docosahexaenoic Acid therapy of experimental ischemic stroke.二十二碳六烯酸治疗实验性缺血性脑卒中。
Transl Stroke Res. 2011 Mar;2(1):33-41. doi: 10.1007/s12975-010-0046-0. Epub 2010 Nov 4.
10
Delayed treatment with a novel neurotrophic compound reduces behavioral deficits in rabbit ischemic stroke.新型神经营养化合物治疗延迟可减轻兔缺血性脑卒中的行为缺陷。
J Neurochem. 2011 Jan;116(1):122-31. doi: 10.1111/j.1471-4159.2010.07090.x. Epub 2010 Dec 2.

Resolving the negative data publication dilemma in translational stroke research.

作者信息

Lapchak Paul A, Zhang John H

机构信息

Translational Research, Cedars-Sinai Medical Center, Department of Neurology, Davis Research Building, Room D-2091, 110N. George Burns Road, Los Angeles, CA 90048, USA.

出版信息

Transl Stroke Res. 2011 Mar 1;2(1):1-6. doi: 10.1007/s12975-010-0057-x.

DOI:10.1007/s12975-010-0057-x
PMID:21666822
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3109983/
Abstract
摘要